Global Sarcopenia Treatment Market, By Treatment Type (Medication, Vitamin/Dietary Supplements and Others), Route of Administration (Oral, Injectable and Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
The sarcopenia treatment market is expected to witness market growth at a rate of 5.60% in the forecast period of 2021 to 2028. Data Bridge Market Research report on sarcopenia treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the out-of-pocket healthcare costs is escalating the growth of sarcopenia treatment market.
Sarcopenia is referred to as the loss of skeletal flesh or muscle mass as a result of aging. Sarcopenia is considered by the decrease in relative weakness, muscular size, absence of stamina, struggle mounting the stairs, and poor balance.
Major factors that are expected to boost the growth of the sarcopenia treatment market in the forecast period are the rise in the incidence of the elderly population and the growing acceptance of vitamins and dietary supplements. Furthermore, the increase in the cases of sarcopenia is further anticipated to propel the growth of the sarcopenia treatment market. Also, the increasing in the research and development activities for the treatment of sarcopenia is further estimated to cushion the growth of the sarcopenia treatment market. On the other hand, the dearth of alertness amongst the people elated to the muscle loss is further projected to impede the growth in the timeline period.
In addition, the growing cases of malnutrition because of poor nutritional intake will further provide potential opportunities for the growth of the sarcopenia treatment market in the coming years. However, the rise in the price of protein supplement and the inaccessibility of sarcopenia treatment drugs might further challenge the growth of the sarcopenia treatment market in the near future.
This sarcopenia treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the sarcopenia treatment market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Sarcopenia Treatment Market Scope and Market Size
The sarcopenia treatment market is segmented on the basis of treatment type, route of administration, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of treatment type, the sarcopenia treatment market is segmented into medication, vitamin or dietary supplements and others.
- On the basis of route of administration, the sarcopenia treatment market is segmented into oral, injectable and others.
- On the basis of end users, the sarcopenia treatment market is segmented into hospitals, homecare, specialty clinics and others.
- On the basis of distribution channel, the sarcopenia treatment market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.
Sarcopenia Treatment Market Country Level Analysis
The sarcopenia treatment market is analysed and market size information is provided by country, treatment type, route of administration, end users and distribution channel as referenced above.
The countries covered in the sarcopenia treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the sarcopenia treatment market due to the rise in the accessibility and the affordability of expensive tests and therapies. Furthermore, the enhanced healthcare facilities and technological breakthroughs and the increase in the sarcopenia will further boost the growth of the sarcopenia treatment market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the sarcopenia treatment market due to the rise in the number of elderly people. Moreover, the growing of the research activities and the growing alertness in the advancing countries is further anticipated to propel the growth of the sarcopenia treatment market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The sarcopenia treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Sarcopenia Treatment Market Share Analysis
The sarcopenia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to sarcopenia treatment market.
The major players covered in the sarcopenia treatment market report are Novartis AG, AstaReal AB, Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Biophytis, Metabolic Technologies, Inc., AbbVie Inc., Danone S.A., Pfizer Inc., Abbott, Biogen, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Nestlé, Mitacs, Sanofi, Bayer AG, Amway, Zydus Cadila, Lilly, Radius Health, Inc., MYSURABLE S.R.L. and PhaseBio Pharmaceuticals, Inc among other domestic and global players. sarcopenia treatment market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Sarcopenia Treatment Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.